Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Karpe

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Diabetologia|July 2, 2005
Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapyG D Tan, C Debard, T Funahashi, et al.
Journal of the American College of Cardiology|November 20, 1998
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)G Ruotolo, C G Ericsson, C Tettamanti, et al.
Circulation|March 14, 1998
Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient miceP K Shah, J Nilsson, S Kaul, et al.
Atherosclerosis|June 28, 2001
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatmentF Karpe, M R Taskinen, M S Nieminen, et al.
International Journal of Obesity (2005)|November 21, 2017
Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease riskS K Vasan, C Osmond, D Canoy, et al.
Diabetologia|December 20, 2005
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford BiobankG D Tan, M J Neville, E Liverani, et al.
Diabetologia|December 25, 2004
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetesG D Tan, B A Fielding, J M Currie, et al.
European Heart Journal|February 16, 2002
Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged menT Skoog, W Dichtl, S Boquist, et al.
Circulation|January 30, 2008
Remodeling phenotype of human subcutaneous adipose tissue macrophagesV Bourlier, A Zakaroff-Girard, A Miranville, et al.
The Journal of Physiology|January 7, 2006
Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humansG H Goossens, S E McQuaid, A L Dennis, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Diabetologia|July 2, 2005
Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapyG D Tan, C Debard, T Funahashi, et al.
Journal of the American College of Cardiology|November 20, 1998
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)G Ruotolo, C G Ericsson, C Tettamanti, et al.
Circulation|March 14, 1998
Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient miceP K Shah, J Nilsson, S Kaul, et al.
Atherosclerosis|June 28, 2001
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatmentF Karpe, M R Taskinen, M S Nieminen, et al.
International Journal of Obesity (2005)|November 21, 2017
Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease riskS K Vasan, C Osmond, D Canoy, et al.
Diabetologia|December 20, 2005
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford BiobankG D Tan, M J Neville, E Liverani, et al.
Diabetologia|December 25, 2004
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetesG D Tan, B A Fielding, J M Currie, et al.
European Heart Journal|February 16, 2002
Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged menT Skoog, W Dichtl, S Boquist, et al.
Circulation|January 30, 2008
Remodeling phenotype of human subcutaneous adipose tissue macrophagesV Bourlier, A Zakaroff-Girard, A Miranville, et al.
The Journal of Physiology|January 7, 2006
Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humansG H Goossens, S E McQuaid, A L Dennis, et al.
Pageof 11